FDA Issues Draft Guidance on Bioresearch Monitoring Inspections
WASHINGTON, D.C. — On Wednesday, the Food and Drug Administration (FDA) released a draft guidance for industry detailing processes and practices for inspections under its Bioresearch Monitoring (BIMO) program. This …
FDA Issues Draft Guidance on Bioresearch Monitoring Inspections Read More